8-K - Immuneering Corporation | StockGist

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On August 21, 2025, Immuneering Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Pur

Material Agreement

$5.50$25.0M$3.95Company, pursuant to which the Company

Source Document

3.02

. Unregistered Sales of Equity Securities. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item

Securities Issuance

8.01

. Other Events. On August 21, 2025, the Company issued a press release announcing the pricing of the Private Placement described above in Item 1.01. A copy of t

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 4.1 Form of Pre-Funded Warrant. 4.2 Form of Purchase Warrant. 10.1# Form of Securities

Exhibits Only

Source Document

Exhibits (6)

10.1

EXHIBIT 10.1

10.2

EXHIBIT 10.2

4.1

EXHIBIT 4.1

4.2

EXHIBIT 4.2

8-K

FORM 8-K

99.1

EXHIBIT 99.1